ID   MSU-1.1-T24 3
AC   CVCL_XG26
SY   MSU-1.1-T24 cell strain 3; PHM3
DR   Wikidata; Q95991332
RX   PubMed=2643097;
RX   PubMed=11888918;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9S81 ! MSU-1.1
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 8
CH   CVCL_XG28 ! PH3MT
//
RX   PubMed=2643097; DOI=10.1073/pnas.86.1.187; PMCID=PMC286429;
RA   Hurlin, Peter J.
RA   Maher, Veronica M.
RA   McCormick, J. Justin
RT   "Malignant transformation of human fibroblasts caused by expression of
RT   a transfected T24 HRAS oncogene.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:187-191(1989).
//
RX   PubMed=11888918;
RA   Havre, Pamela A.
RA   O'Reilly, Sandra
RA   McCormick, J. Justin
RA   Brash, Douglas E.
RT   "Transformed and tumor-derived human cells exhibit preferential
RT   sensitivity to the thiol antioxidants, N-acetyl cysteine and
RT   penicillamine.";
RL   Cancer Res. 62:1443-1449(2002).
//